Larvol Delta - Dalpiciclib-with-or-without-Camrelizumab-in-patients-with-advanced-Intrahepatic-Cholangiocarcinoma-after-failure-or-intolerance-of-firstline-therapy-A-prospective-doubleCohort-phase-b-study

Darzalex (daratumumab) - J&J

AiRuiKang (dalpiciclib) - Jiangsu Hengrui Pharma

AiRuiKa (camrelizumab) - Elevar Therapeutics

https://www.chictr.org.cn/showproj.html?proj=318403

Jul 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next